• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血型决定德国胰腺癌的发病率。

Blood group determinates incidence for pancreatic cancer in Germany.

机构信息

Department of Hematology/Oncology, Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin Berlin, Germany.

出版信息

Front Physiol. 2013 May 24;4:118. doi: 10.3389/fphys.2013.00118. eCollection 2013.

DOI:10.3389/fphys.2013.00118
PMID:23745115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3662880/
Abstract

BACKGROUND

Genetic risk factors for sporadic pancreatic cancer are largely unknown but actually under high exposure. Findings of correlations between the AB0 blood group system (Chromosome 9q34,1-q34,2) and the risk of pancreatic cancer (PC) in patients from Asia, America and south Europe have already been published. So far it is unclear, whether this correlation between blood group an PC incidence can be found in German patients as well.

METHODS

One hundred and sixty-six patients who underwent a resection of PC were evaluated in a period between 2000 and 2010. Blood group reference distribution for the German population is given as: 0: 41%; A: 43%; B: 11%; AB: 5%; Rhesus positive: 85%; Rhesus negative: 15%. Analyses were done using the non-parametric Chi(2)-test (p-value two sided; SPSS 19.0).

RESULTS

Median age was 62 (34-82) years. Gender: female 73/44%; male: 93/56%. Observed blood group proportions: 0: 43 (25.9%)/A: 94 (56.6%)/B: 16 (9.6%)/AB: 13 (7.8%)/Rhesus positive: 131 (78.9%)/negative: 35 (21.1%). We detected a significant difference to the German reference distribution of the AB0 system (Chi(2) 19.34, df 3, p < 0.001). Rhesus factor has no impact on AB0-distribution (Chi(2) 4.13, df 3, p = 0.25), but differs significantly from reference distribution-probably due to initial AB0-variation (Chi(2) 4.82, df 1, p = 0.028). The odds ratio for blood group A is 2.01 and for blood group 0 is 0.5.

CONCLUSIONS

The incidence of PC in the German cohort is highly associated with the AB0-system as well. More patients with blood group A suffer from PC (p < 0.001) whereas blood group 0 was less frequent in patients with PC (p < 0.001). Thus, our findings support the results from other non-German surveys. The causal trigger points of this carcinogenesis correlation are still not known.

摘要

背景

散发性胰腺癌的遗传风险因素很大程度上是未知的,但实际上处于高暴露状态。已经发表了关于 AB0 血型系统(染色体 9q34、1-q34、2)与亚洲、美洲和南欧胰腺癌(PC)患者风险之间的相关性的发现。到目前为止,尚不清楚这种血型与 PC 发病率之间的相关性是否也能在德国患者中找到。

方法

我们评估了 2000 年至 2010 年间接受胰腺切除术的 166 名 PC 患者。德国人群的血型参考分布为:0 型:41%;A 型:43%;B 型:11%;AB 型:5%;Rh 阳性:85%;Rh 阴性:15%。使用非参数 Chi(2)-检验(双侧 p 值;SPSS 19.0)进行分析。

结果

中位年龄为 62(34-82)岁。性别:女性 73/44%;男性:93/56%。观察到的血型比例:0 型:43(25.9%)/A 型:94(56.6%)/B 型:16(9.6%)/AB 型:13(7.8%)/Rh 阳性:131(78.9%)/Rh 阴性:35(21.1%)。我们检测到 AB0 系统与德国参考分布之间存在显著差异(Chi(2) 19.34,df 3,p < 0.001)。Rh 因子对 AB0 分布没有影响(Chi(2) 4.13,df 3,p = 0.25),但与参考分布显著不同-可能是由于初始 AB0 变异(Chi(2) 4.82,df 1,p = 0.028)。血型 A 的优势比为 2.01,血型 0 的优势比为 0.5。

结论

德国队列中 PC 的发病率与 AB0 系统高度相关。患有 A 型血的 PC 患者更多(p < 0.001),而患有 PC 的 0 型血患者较少(p < 0.001)。因此,我们的研究结果支持来自其他非德国调查的结果。这种癌变相关性的因果触发因素尚不清楚。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1275/3662880/78f82d797e17/fphys-04-00118-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1275/3662880/78f82d797e17/fphys-04-00118-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1275/3662880/78f82d797e17/fphys-04-00118-g0001.jpg

相似文献

1
Blood group determinates incidence for pancreatic cancer in Germany.血型决定德国胰腺癌的发病率。
Front Physiol. 2013 May 24;4:118. doi: 10.3389/fphys.2013.00118. eCollection 2013.
2
The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy.AB0和恒河猴血型系统对接受根治性膀胱切除术的膀胱癌患者治疗结果的影响。
World J Urol. 2015 Nov;33(11):1769-76. doi: 10.1007/s00345-015-1531-6. Epub 2015 Mar 18.
3
The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma.ABO和恒河猴血型系统对接受根治性肾输尿管切除术治疗上尿路尿路上皮癌患者肿瘤学结局的影响。
Urol Oncol. 2017 Dec;35(12):671.e17-671.e23. doi: 10.1016/j.urolonc.2017.08.007. Epub 2017 Sep 8.
4
AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer - a retrospective multi-centre study.AB0 血型和 Rh 因子表达作为上皮性卵巢癌患者的预后参数 - 一项回顾性多中心研究。
BMC Cancer. 2018 Apr 19;18(1):447. doi: 10.1186/s12885-018-4289-6.
5
AB0 blood group and prognosis in patients with pancreatic cancer.AB0 血型与胰腺癌患者预后的关系。
BMC Cancer. 2012 Jul 28;12:319. doi: 10.1186/1471-2407-12-319.
6
[The effect of ABO, Rhesus and Kell blood group antigens on gallstone prevalence. A sonographic study of 1030 blood donors].[ABO、恒河猴和凯尔血型抗原对胆结石患病率的影响。对1030名献血者的超声检查研究]
Dtsch Med Wochenschr. 1999 May 14;124(19):579-83. doi: 10.1055/s-2007-1024362.
7
ABO blood group and the risk of pancreatic cancer.ABO血型与胰腺癌风险
J Natl Cancer Inst. 2009 Mar 18;101(6):424-31. doi: 10.1093/jnci/djp020. Epub 2009 Mar 10.
8
Do AB0 blood groups affect lower urinary tract symptoms?ABO血型会影响下尿路症状吗?
Turk J Urol. 2019 Dec;45(Supp. 1):S84-S91. doi: 10.5152/tud.2018.25295. Epub 2018 Nov 19.
9
The role of ABO blood groups in glial neoplasms.ABO血型在胶质肿瘤中的作用。
Br J Neurosurg. 2019 Feb;33(1):43-46. doi: 10.1080/02688697.2018.1522415. Epub 2018 Nov 4.
10
Is ABO blood group a risk or prognostic factor for patients with endometrioid endometrial cancer? A retrospective analysis in Germany.ABO 血型是否为子宫内膜样子宫内膜癌患者的风险或预后因素?德国的一项回顾性分析。
Blood Transfus. 2020 Nov;18(6):465-470. doi: 10.2450/2020.002-20. Epub 2020 Jun 4.

引用本文的文献

1
Association of long non-coding RNAs and ABO blood groups with acute lymphoblastic leukemia in Egyptian children.埃及儿童中长链非编码RNA和ABO血型与急性淋巴细胞白血病的关联
Noncoding RNA Res. 2024 Jan 18;9(2):307-317. doi: 10.1016/j.ncrna.2024.01.010. eCollection 2024 Jun.
2
Relationship between ABO Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor (FUT2) Genotype, but Not Lewis Antigen (FUT3) Genotype.ABO 血型等位基因与胰腺癌的关系受分泌型(FUT2)基因型调节,但不受 Lewis 抗原(FUT3)基因型调节。
Cancer Epidemiol Biomarkers Prev. 2023 Sep 1;32(9):1242-1248. doi: 10.1158/1055-9965.EPI-23-0009.
3

本文引用的文献

1
Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study.韩国人群中 ABO 血型与丙型肝炎病毒感染与胰腺癌风险的关系:一项病例对照研究。
J Korean Med Sci. 2013 Feb;28(2):247-51. doi: 10.3346/jkms.2013.28.2.247. Epub 2013 Jan 29.
2
A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk.一项全基因组关联研究,旨在发现影响肿瘤标志物癌抗原 19-9、癌胚抗原和甲胎蛋白的遗传位点,及其与癌症风险的关联。
Gut. 2014 Jan;63(1):143-51. doi: 10.1136/gutjnl-2012-303434. Epub 2013 Jan 7.
3
ABO Blood Group and the Risk and Prognosis of Lymphoma.
ABO血型与淋巴瘤的风险及预后
J Inflamm Res. 2023 Feb 22;16:769-778. doi: 10.2147/JIR.S401818. eCollection 2023.
4
Association of blood groups on the risk of COVID-19 infection, morbidity, and mortality.血型与新型冠状病毒肺炎感染、发病及死亡风险的关联
North Clin Istanb. 2021 May 26;8(3):298-305. doi: 10.14744/nci.2021.91328. eCollection 2021.
5
ABO blood groups in COVID-19 patients; Cross-sectional study.COVID-19患者的ABO血型;横断面研究。
Int J Clin Pract. 2021 Apr;75(4):e13927. doi: 10.1111/ijcp.13927. Epub 2020 Dec 19.
6
The Effect of Autophagic Activity on the Function of Apheresis Platelets and on the Efficacy of Clinical Platelet Transfusion.自噬活性对单采血小板功能及临床血小板输注疗效的影响
Transfus Med Hemother. 2020 Jul;47(4):302-313. doi: 10.1159/000504764. Epub 2020 Jan 7.
7
Do AB0 blood groups affect lower urinary tract symptoms?ABO血型会影响下尿路症状吗?
Turk J Urol. 2019 Dec;45(Supp. 1):S84-S91. doi: 10.5152/tud.2018.25295. Epub 2018 Nov 19.
8
AB0/Rhesus Blood Group Does Not Influence Clinicopathological Tumor Characteristics or Oncological Outcome in Patients Undergoing Radical Prostatectomy.ABO/Rh血型不影响接受根治性前列腺切除术患者的临床病理肿瘤特征或肿瘤学结局。
Front Surg. 2017 Dec 18;4:75. doi: 10.3389/fsurg.2017.00075. eCollection 2017.
9
Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival.ABO血型与胰腺导管腺癌之间的关联:对切除状态和生存的影响。
Cancer Med. 2017 Jul;6(7):1531-1540. doi: 10.1002/cam4.1097. Epub 2017 May 29.
10
The role of the histoblood ABO group in cancer.组织血型ABO血型系统在癌症中的作用。
Future Sci OA. 2016 Mar 15;2(2):FSO107. doi: 10.4155/fsoa-2015-0012. eCollection 2016 Jun.
Demographics and epidemiology of pancreatic cancer.
胰腺癌的人口统计学和流行病学。
Cancer J. 2012 Nov-Dec;18(6):477-84. doi: 10.1097/PPO.0b013e3182756803.
4
ABO blood group and risk of pancreatic cancer in a Turkish population in Western Blacksea region.西黑海地区土耳其人群中的ABO血型与胰腺癌风险
Asian Pac J Cancer Prev. 2012;13(1):131-3.
5
ABO blood type, diabetes and risk of gastrointestinal cancer in northern China.ABO 血型、糖尿病与中国北方地区胃肠道癌发病风险的关系
World J Gastroenterol. 2012 Feb 14;18(6):563-9. doi: 10.3748/wjg.v18.i6.563.
6
Pancreatic cancer: Helicobacter pylori colonization, N-nitrosamine exposures, and ABO blood group.胰腺癌:幽门螺杆菌定植、亚硝胺暴露和 ABO 血型。
Mol Carcinog. 2012 Jan;51(1):109-18. doi: 10.1002/mc.20826.
7
ABO blood group and chronic pancreatitis risk in the NAPS2 cohort.ABO 血型与 NAPS2 队列中慢性胰腺炎风险的关系。
Pancreas. 2011 Nov;40(8):1188-94. doi: 10.1097/MPA.0b013e3182232975.
8
Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group.二线治疗晚期胰腺癌患者的最佳支持治疗(BSC)对比奥沙利铂、亚叶酸钙和 5-氟尿嘧啶(OFF)加 BSC:德国 CONKO 研究组的 III 期研究。
Eur J Cancer. 2011 Jul;47(11):1676-81. doi: 10.1016/j.ejca.2011.04.011. Epub 2011 May 10.
9
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.FOLFIRINOX 对比吉西他滨治疗转移性胰腺癌。
N Engl J Med. 2011 May 12;364(19):1817-25. doi: 10.1056/NEJMoa1011923.
10
ABO blood group and risk of colorectal cancer.ABO 血型与结直肠癌风险。
Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):1017-20. doi: 10.1158/1055-9965.EPI-10-1250. Epub 2011 Mar 17.